Immunosuppressive properties of human umbilical cord‐derived mesenchymal stem cells: role of B7‐H1 and IDO
- 13 April 2010
- journal article
- Published by Wiley in Immunology & Cell Biology
- Vol. 88 (8), 795-806
- https://doi.org/10.1038/icb.2010.47
Abstract
Umbilical cord is a rich source of mesenchymal stromal or stem cells (MSCs) that can be used for developing allogeneic cell therapy to treat intractable diseases. In this report, we present evidence that umbilical cord-derived MSCs (UCMSCs) possess important immunomodulatory properties that may enable them to survive in an allogeneic environment. UCMSCs do not express human leukocyte antigen (HLA)-DR and co-stimulatory molecules CD80 and CD86 that are required for T-cell activation. More importantly, UCMSCs constitutively express a negative regulator of T-cell activation, B7-H1, and its expression is increased after interferon-γ (IFN-γ) treatment. In addition, IFN-γ treatment induced indoleamine 2,3-dioxygenase (IDO) and HLA-DR expression in UCMSCs. Neither control nor IFN-γ-treated UCMSCs stimulated allogeneic T-cell proliferation, and both cell populations inhibited third-party dendritic cell (DC)-mediated allostimulatory activity. Addition of a B7-H1-specific blocking antibody or an IDO inhibitor, 1 methyl tryptophan (1-MT) abrogated the T-cell immunosuppressive activity of these cells. Furthermore, UCMSCs prevented the differentiation and maturation of peripheral blood monocyte-derived DCs, and augmented the generation of regulatory T cells (Tregs) in culture. The immunosuppressive effects of UCMSCs are largely mediated by cell-to-cell contact, although some inhibitory activity was observed with cell-free supernatant. Our study suggests that these immunomodulatory properties of UCMSCs could potentially improve the outcome of allogeneic stem cell therapy.Keywords
Funding Information
- Reliance Life Sciences Pvt. Ltd
This publication has 49 references indexed in Scilit:
- Comparison of proliferative and multilineage differentiation potentials of cord matrix, cord blood, and bone marrow mesenchymal stem cellsAsian Journal of Transfusion Science, 2010
- Concise Review: Wharton's Jelly-Derived Cells Are a Primitive Stromal Cell PopulationThe International Journal of Cell Cloning, 2007
- Multipotent Stem Cells from Umbilical Cord: Cord Is Richer than Blood!The International Journal of Cell Cloning, 2007
- Concise Review: Mesenchymal Stem Cells: Their Phenotype, Differentiation Capacity, Immunological Features, and Potential for HomingThe International Journal of Cell Cloning, 2007
- Interferon-γ does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cellsClinical and Experimental Immunology, 2007
- Immunoregulatory function of mesenchymal stem cellsEuropean Journal of Immunology, 2006
- Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, or Adipose TissueThe International Journal of Cell Cloning, 2006
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cellsBlood, 2005
- Mesenchymal Stem Cells in the Wharton's Jelly of the Human Umbilical CordThe International Journal of Cell Cloning, 2004